The Effect of Home-Based Walking on Symptoms and Health Profile of Hemodialysis Patients

NCT ID: NCT07272070

Last Updated: 2025-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of 8 weeks of home-based moderate-speed walking on hemodialysis symptoms and health profile while patients are receiving hemodialysis treatment.

Due to permanent deterioration in kidney function, patients need hemodialysis treatment, which is the most commonly used treatment method among renal replacement therapies. Hemodialysis treatment causes a series of physical and psychological problems. Problems such as hypotension, headache, nausea, muscle cramps, itching and pain are physical problems, while depression, anxiety, cognitive disorders and stress are psychological problems. In addition, it has been reported that long-term hemodialysis treatment and all the resulting problems increase the tendency to a sedentary lifestyle in this patient group, leading to a decrease in physical function and activity, and indirectly to a low quality of life and low survival rates. For this reason, hemodialysis patients have difficulty meeting their daily activities and needs, and their dependency and healthcare burden increase. Adopting a sedentary lifestyle by these patients prevents them from managing both the physical and psychological problems of hemodialysis and their conditions such as hypertension and diabetes mellitus, and causes the disease to progress. Physical exercises, which are considered among the useful therapeutic suggestions in addition to pharmacological treatments in the management of the negative situations that arise, are considered as an easy, useful and effective intervention method. Kidney Disease: Improving Global Outcomes (KDIGO) recommends 30 minutes of moderate-intensity physical exercise at least 5 days a week. Additionally, it should not be overlooked that whether patients have places to do physical activity and what their facilities are are a detail that should be questioned by health professionals. Patients without suitable accommodations should be encouraged to engage in physical activity, especially in indoor spaces like home. Home-based walking exercise is known to be easy, inexpensive, and safe, and is also advantageous when the weather is not favorable. When we examined the studies in which home-based walking exercise was performed, it was determined that its effect on functional capacity was generally investigated, but its effect on the health outcomes and symptoms of patients receiving hemodialysis treatment was not evaluated. There was no evidence that home-based walking exercise had any effect on symptoms in patients receiving HD treatment. Therefore, it was planned to conduct a study to evaluate whether home-based walking exercise has an effect on patient health outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Cramp Hemodialysis Vibration Stretching

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A (Home-based walking)

Home-based walking

Group Type EXPERIMENTAL

Group A (Home-based walking)

Intervention Type OTHER

Verbal and written consent was obtained from patients who met the sampling criteria. At the first meeting, the Dialysis Symptom Index and Nottingham Health Profile will be assessed. Information was given about the pedometer tracking form and things to consider for walking exercises at home. Patients were asked to choose comfortable, lightweight athletic shoes that would hug their feet. The patient will be asked to walk on flat ground at home and wear cotton, non-sweaty clothes. It is necessary to walk forward at a moderate intensity 5 days a week. It will be explained that 6,000 steps should be taken in the first week and increased by 10% the following week. During the hemodialysis session, the tracking form will be checked with the pedometer application on the patient's smartphone. This group of patients will be asked to answer again in the 1st and 2nd months to see the change in the Dialysis Symptom Index and Nottingham Health Profile.

Group B (Usual hemodialysis care )

Usual hemodialysis care

Group Type EXPERIMENTAL

Group B (Usual hemodialysis care )

Intervention Type OTHER

Before starting the study, verbal and written consent will be obtained from patients who meet the sampling criteria. Patient identification forms will be completed. At the initial visit, patients' Dialysis Symptom Index and Nottingham Health Profile will be assessed, and this assessment will be recorded as week 0. Patients will be instructed to record their step count on the pedometer section of their smartphone at the end of each day. During each hemodialysis session, researchers will check the follow-up form using the pedometer application on the patient's smartphone and discuss daily care practices. This group of patients will be asked to answer again in the 1st and 2nd months to see the change in the Dialysis Symptom Index and Nottingham Health Profile.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group A (Home-based walking)

Verbal and written consent was obtained from patients who met the sampling criteria. At the first meeting, the Dialysis Symptom Index and Nottingham Health Profile will be assessed. Information was given about the pedometer tracking form and things to consider for walking exercises at home. Patients were asked to choose comfortable, lightweight athletic shoes that would hug their feet. The patient will be asked to walk on flat ground at home and wear cotton, non-sweaty clothes. It is necessary to walk forward at a moderate intensity 5 days a week. It will be explained that 6,000 steps should be taken in the first week and increased by 10% the following week. During the hemodialysis session, the tracking form will be checked with the pedometer application on the patient's smartphone. This group of patients will be asked to answer again in the 1st and 2nd months to see the change in the Dialysis Symptom Index and Nottingham Health Profile.

Intervention Type OTHER

Group B (Usual hemodialysis care )

Before starting the study, verbal and written consent will be obtained from patients who meet the sampling criteria. Patient identification forms will be completed. At the initial visit, patients' Dialysis Symptom Index and Nottingham Health Profile will be assessed, and this assessment will be recorded as week 0. Patients will be instructed to record their step count on the pedometer section of their smartphone at the end of each day. During each hemodialysis session, researchers will check the follow-up form using the pedometer application on the patient's smartphone and discuss daily care practices. This group of patients will be asked to answer again in the 1st and 2nd months to see the change in the Dialysis Symptom Index and Nottingham Health Profile.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who agreed to participate in the research during the data collection process,
* Over 18 years of age,
* Speak and understand Turkish,
* Are at least literate,
* Can perform daily living activities independently,
* Own a smartphone.

Exclusion Criteria

* Do not have sufficient cognitive ability,
* Have arthritic or orthopedic problems requiring assistance with walking,
* Have significant visual or hearing impairments,
* Walk regularly,
* Have a hemoglobin level \<8 mg/dl,
* Have Stage IV of New York heart failure.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Figen Akay

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Figen Akay

Specialist Nurse

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara Bilkent City Hospital

Ankara, Çankaya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Figen Akay, Specialist Nurse

Role: CONTACT

+905368561105

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Figen Akay

Role: primary

0312 552 60 00

References

Explore related publications, articles, or registry entries linked to this study.

Machfer A, Fekih N, Ammar A, Hassen HBH, Daab W, Amor HH, Bouzid MA, Chtourou H. Effects of neuromuscular electrical stimulation during hemodialysis on muscle strength, functional capacity and postural balance in patients with end-stage renal disease: a randomized controlled trial. BMC Nephrol. 2025 Feb 19;26(1):86. doi: 10.1186/s12882-025-03994-8.

Reference Type RESULT
PMID: 39972246 (View on PubMed)

Manfredini F, Mallamaci F, D'Arrigo G, Baggetta R, Bolignano D, Torino C, Lamberti N, Bertoli S, Ciurlino D, Rocca-Rey L, Barilla A, Battaglia Y, Rapana RM, Zuccala A, Bonanno G, Fatuzzo P, Rapisarda F, Rastelli S, Fabrizi F, Messa P, De Paola L, Lombardi L, Cupisti A, Fuiano G, Lucisano G, Summaria C, Felisatti M, Pozzato E, Malagoni AM, Castellino P, Aucella F, Abd ElHafeez S, Provenzano PF, Tripepi G, Catizone L, Zoccali C. Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. J Am Soc Nephrol. 2017 Apr;28(4):1259-1268. doi: 10.1681/ASN.2016030378. Epub 2016 Dec 1.

Reference Type RESULT
PMID: 27909047 (View on PubMed)

Koh KP, Fassett RG, Sharman JE, Coombes JS, Williams AD. Effect of intradialytic versus home-based aerobic exercise training on physical function and vascular parameters in hemodialysis patients: a randomized pilot study. Am J Kidney Dis. 2010 Jan;55(1):88-99. doi: 10.1053/j.ajkd.2009.09.025. Epub 2009 Nov 22.

Reference Type RESULT
PMID: 19932545 (View on PubMed)

Hiraki K, Shibagaki Y, Izawa KP, Hotta C, Wakamiya A, Sakurada T, Yasuda T, Kimura K. Effects of home-based exercise on pre-dialysis chronic kidney disease patients: a randomized pilot and feasibility trial. BMC Nephrol. 2017 Jun 17;18(1):198. doi: 10.1186/s12882-017-0613-7.

Reference Type RESULT
PMID: 28623895 (View on PubMed)

Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P, Ferguson J, Horton M, Paap MCS, Sidey-Gibbons C, Slade A, Turner N, Kyte D. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. PLoS Med. 2022 Apr 6;19(4):e1003954. doi: 10.1371/journal.pmed.1003954. eCollection 2022 Apr.

Reference Type RESULT
PMID: 35385471 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TABED 2-25-942

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resistance Exercise in Hemodialysis Patients
NCT06604221 NOT_YET_RECRUITING NA